PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Capital expenditures 2010–2018
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$30,400FY2018 · since FY2010: $5,839 → $30,400
| Fiscal year | Value | YoY |
|---|---|---|
| FY2018 | $30,400 | — |
| FY2016 | $6,139 | -91.3% |
| FY2015 | $70,590 | +961.5% |
| FY2014 | $6,650 | -58.1% |
| FY2013 | $15,885 | +158.4% |
| FY2012 | $6,147 | — |
| FY2010 | $5,839 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice